Related Podcast
Part 3 - Strategies for Educating the APP Community on MASH
2024
GHAPPcast: Recognizing the Severity of MASH
2025
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2025
What Is Resmetirom and How Does It Work to Treat MASH?
2025
What Are the Consequences of MASH Going Untreated?
2025
What is MASH?
2025
Part 4 - MASH- What We Don't Know, What We Want to Know
2024
How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?
2025
What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?
2025
Part 2 - Using NITs to Identify and Manage MASH Patients
2024